Motif Bio announced that Stephanie Noviello, MD, MPH has joined the Company as vice president, Clinical Development.  She will report to David Huang, MD, PhD, chief medical officer, and will be a key contributor to the European Marketing Authorisation Application submission for iclaprim. Dr. Noviello joins Motif Bio from Bristol-Myers Squibb, where she most recently was clinical program lead, Virology.  In this position, she served as clinical lead for the hepatitis B and C and HIV portfo...